查看購物車
  • English
  • Japanese
2026-2030年生命科學領域生成式人工智慧全球市場
市場調查報告書
商品編碼
2056212

2026-2030年生命科學領域生成式人工智慧全球市場

Global Generative AI In Life Sciences Market 2026-2030
出版日期: | 出版商: TechNavio | 英文 294 Pages | 訂單完成後即時交付

價格
簡介目錄

預計從 2025 年到 2030 年，生命科學領域生成式人工智慧的全球市場規模將成長至 17.252 億美元，預測期內複合年成長率為 25.4%。

本報告對生命科學領域的全球生成式人工智慧市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動此市場發展的因素包括：從頭分子設計和治療方法發現的加速發展、臨床試驗設計和患者分層的最佳化，以及透過多模態基因組數據整合實現的精準醫療的擴展。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告中包含歷史資料和預測資料。

市場範圍
基準年 2025
年末 2030
調查期 2026-2030
成長勢頭 加速度
與 2026 年相比 19.9%
複合年成長率 25.4%
增量 17.252億美元

本研究指出，自主代理研究工作流程的產業化是未來幾年全球生命科學生成式人工智慧市場成長的關鍵促進因素之一。此外，合成數位雙胞胎在臨床開發中的應用以及多模態知識與藥物發現平台的整合也將產生顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

  • 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 干擾因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場的定義
  • 市場區隔分析
  • 2025年市場規模
  • 市場展望，2025-2030年

第5章 市場規模與表現

  • 2020-2024年全球生命科學領域生成式人工智慧市場
  • 基於應用領域的細分市場分析，2020-2024 年
  • 2020-2024年基於技術的細分市場分析
  • 按部署方式分類的細分市場分析，2020-2024 年
  • 區域區隔市場分析，2020-2024 年
  • 2020-2024年各國細分市場分析

第6章 定性分析

  • 地緣政治衝突的影響：生命科學領域全球生成式人工智慧市場

第7章：五力分析

第8章 市場區隔：依應用領域

  • 比較：透過應用
  • 藥物發現
  • 個人化醫療
  • 臨床試驗
  • 市場機會：依應用領域分類

第9章 市場區隔：依技術分類

  • 比較：按技術
  • 新型分子的創造
  • 蛋白質序列設計
  • 合成基因設計
  • 市場機會：依技術分類

第10章 市場區隔：依部署方式

  • 比較：依部署方式
  • 基於雲端的
  • 現場
  • 混合
  • 市場機會：依發展階段分類

第11章 客戶情況

第12章 區域情勢

  • 區域分類
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 荷蘭
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
  • 中東和非洲
    • 以色列
    • 沙烏地阿拉伯
    • UAE
    • 南非
    • 土耳其
  • 南美洲
    • 巴西
    • 阿根廷
    • 智利
  • 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 混亂局面
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • Atomwise Inc.
  • BenchSci Analytics Inc.
  • Deep Genomics Inc.
  • Iktos SA
  • Insilico Medicine
  • IQVIA Holdings Inc.
  • Isomorphic Labs
  • NVIDIA Corp.
  • Owkin Inc.
  • Recursion Pharmaceuticals Inc.
  • Schrodinger Inc.
  • Tempus AI Inc.
  • Valo Health
  • Veeva Systems Inc.
  • Verge Analytics Inc.

第16章附錄

簡介目錄
Product Code: IRTNTR80727

The global generative ai in life sciences market is forecasted to grow by USD 1725.2 mn during 2025-2030, accelerating at a CAGR of 25.4% during the forecast period. The report on the global generative ai in life sciences market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by acceleration of de novo molecular design and therapeutic discovery, optimization of clinical trial design and patient stratification efficiency, expansion of precision medicine through multimodal genomic data integration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 202619.9%
CAGR25.4%
Incremental Value$1725.2 mn

Technavio's global generative ai in life sciences market is segmented as below:

By Application

  • Drug discovery
  • Personalized medicine
  • Clinical trials

By Technology

  • Novel molecule generation
  • Protein sequence design
  • Synthetic gene design

By Deployment

  • Cloud-based
  • On-premises
  • Hybrid

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • The Netherlands
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
  • Middle East and Africa
    • UAE
    • South Africa
    • Turkey
  • South America
    • Brazil
    • Argentina
    • Chile
  • Rest of World (ROW)

This study identifies the industrialization of autonomous agentic research workflows as one of the prime reasons driving the global generative ai in life sciences market growth during the next few years. Also, adoption of synthetic digital twins in clinical development and integration of multimodal knowledge to target discovery platforms will lead to sizable demand in the market.

The report on the global generative ai in life sciences market covers the following areas:

  • Global generative ai in life sciences market sizing
  • Global generative ai in life sciences market forecast
  • Global generative ai in life sciences market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global generative ai in life sciences market vendors that include Atomwise Inc., BenchSci Analytics Inc., Deep Genomics Inc., Evogene Ltd., Iktos SA, Indegene Ltd, Insilico Medicine, insitro, IQVIA Holdings Inc., Isomorphic Labs, NVIDIA Corp., Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Schrodinger Inc., Tempus AI Inc., Valo Health, Veeva Systems Inc., Verge Analytics Inc.. Also, the global generative ai in life sciences market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Market Segmentation by Deployment
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Generative AI In Life Sciences Market 2020 - 2024
    • Historic Market Size - Data Table on Global Generative AI In Life Sciences Market 2020 - 2024 ($ million)
  • 5.2 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.3 Technology segment analysis 2020 - 2024
    • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
  • 5.4 Deployment segment analysis 2020 - 2024
    • Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of geopolitical conflict for global generative AI in life sciences market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Application

  • 8.1 Market segments
  • 8.2 Comparison by Application
  • 8.3 Drug discovery - Market size and forecast 2025-2030
  • 8.4 Personalized medicine - Market size and forecast 2025-2030
  • 8.5 Clinical trials - Market size and forecast 2025-2030
  • 8.6 Market opportunity by Application
    • Market opportunity by Application ($ million)

9 Market Segmentation by Technology

  • 9.1 Market segments
  • 9.2 Comparison by Technology
  • 9.3 Novel molecule generation - Market size and forecast 2025-2030
  • 9.4 Protein sequence design - Market size and forecast 2025-2030
  • 9.5 Synthetic gene design - Market size and forecast 2025-2030
  • 9.6 Market opportunity by Technology
    • Market opportunity by Technology ($ million)

10 Market Segmentation by Deployment

  • 10.1 Market segments
  • 10.2 Comparison by Deployment
  • 10.3 Cloud-based - Market size and forecast 2025-2030
  • 10.4 On-premises - Market size and forecast 2025-2030
  • 10.5 Hybrid - Market size and forecast 2025-2030
  • 10.6 Market opportunity by Deployment
    • Market opportunity by Deployment ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 The Netherlands - Market size and forecast 2025-2030
    • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.5 APAC - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 Japan - Market size and forecast 2025-2030
    • 12.5.3 India - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Australia - Market size and forecast 2025-2030
    • 12.5.6 Indonesia - Market size and forecast 2025-2030
  • 12.6 Middle East and Africa - Market size and forecast 2025-2030
    • 12.6.1 Israel - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 UAE - Market size and forecast 2025-2030
    • 12.6.4 South Africa - Market size and forecast 2025-2030
    • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.7 South America - Market size and forecast 2025-2030
    • 12.7.1 Brazil - Market size and forecast 2025-2030
    • 12.7.2 Argentina - Market size and forecast 2025-2030
    • 12.7.3 Chile - Market size and forecast 2025-2030
  • 12.8 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Acceleration of De novo molecular design and therapeutic discovery
    • Optimization of clinical trial design and patient stratification efficiency
    • Expansion of precision medicine through multimodal genomic data integration
  • 13.2 Market challenges
    • Data integrity hurdles and risk of algorithmic hallucination
    • Escalating regulatory complexity and evolving compliance mandates
    • Acute shortages of specialized interdisciplinary talent
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Industrialization of autonomous agentic research workflows
    • Adoption of synthetic digital twins in clinical development
    • Integration of multimodal knowledge to target discovery platforms

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Atomwise Inc.
    • Atomwise Inc. - Overview
    • Atomwise Inc. - Product / Service
    • Atomwise Inc. - Key offerings
    • SWOT
  • 15.5 BenchSci Analytics Inc.
    • BenchSci Analytics Inc. - Overview
    • BenchSci Analytics Inc. - Product / Service
    • BenchSci Analytics Inc. - Key offerings
    • SWOT
  • 15.6 Deep Genomics Inc.
    • Deep Genomics Inc. - Overview
    • Deep Genomics Inc. - Product / Service
    • Deep Genomics Inc. - Key offerings
    • SWOT
  • 15.7 Iktos SA
    • Iktos SA - Overview
    • Iktos SA - Product / Service
    • Iktos SA - Key news
    • Iktos SA - Key offerings
    • SWOT
  • 15.8 Insilico Medicine
    • Insilico Medicine - Overview
    • Insilico Medicine - Product / Service
    • Insilico Medicine - Key offerings
    • SWOT
  • 15.9 IQVIA Holdings Inc.
    • IQVIA Holdings Inc. - Overview
    • IQVIA Holdings Inc. - Business segments
    • IQVIA Holdings Inc. - Key offerings
    • IQVIA Holdings Inc. - Segment focus
    • SWOT
  • 15.10 Isomorphic Labs
    • Isomorphic Labs - Overview
    • Isomorphic Labs - Product / Service
    • Isomorphic Labs - Key offerings
    • SWOT
  • 15.11 NVIDIA Corp.
    • NVIDIA Corp. - Overview
    • NVIDIA Corp. - Business segments
    • NVIDIA Corp. - Key news
    • NVIDIA Corp. - Key offerings
    • NVIDIA Corp. - Segment focus
    • SWOT
  • 15.12 Owkin Inc.
    • Owkin Inc. - Overview
    • Owkin Inc. - Product / Service
    • Owkin Inc. - Key offerings
    • SWOT
  • 15.13 Recursion Pharmaceuticals Inc.
    • Recursion Pharmaceuticals Inc. - Overview
    • Recursion Pharmaceuticals Inc. - Product / Service
    • Recursion Pharmaceuticals Inc. - Key offerings
    • SWOT
  • 15.14 Schrodinger Inc.
    • Schrodinger Inc. - Overview
    • Schrodinger Inc. - Business segments
    • Schrodinger Inc. - Key news
    • Schrodinger Inc. - Key offerings
    • Schrodinger Inc. - Segment focus
    • SWOT
  • 15.15 Tempus AI Inc.
    • Tempus AI Inc. - Overview
    • Tempus AI Inc. - Product / Service
    • Tempus AI Inc. - Key offerings
    • SWOT
  • 15.16 Valo Health
    • Valo Health - Overview
    • Valo Health - Product / Service
    • Valo Health - Key offerings
    • SWOT
  • 15.17 Veeva Systems Inc.
    • Veeva Systems Inc. - Overview
    • Veeva Systems Inc. - Business segments
    • Veeva Systems Inc. - Key offerings
    • Veeva Systems Inc. - Segment focus
    • SWOT
  • 15.18 Verge Analytics Inc.
    • Verge Analytics Inc. - Overview
    • Verge Analytics Inc. - Product / Service
    • Verge Analytics Inc. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations